CN104892494B - 一种4,4'‑二甲基‑2,2'‑联吡啶的制备方法 - Google Patents

一种4,4'‑二甲基‑2,2'‑联吡啶的制备方法 Download PDF

Info

Publication number
CN104892494B
CN104892494B CN201510291441.6A CN201510291441A CN104892494B CN 104892494 B CN104892494 B CN 104892494B CN 201510291441 A CN201510291441 A CN 201510291441A CN 104892494 B CN104892494 B CN 104892494B
Authority
CN
China
Prior art keywords
reaction
added
dimethyl
picolines
room temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201510291441.6A
Other languages
English (en)
Other versions
CN104892494A (zh
Inventor
过治军
张玮玮
郭利兵
李玉江
许霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henan Normal University
Original Assignee
Henan Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henan Normal University filed Critical Henan Normal University
Priority to CN201510291441.6A priority Critical patent/CN104892494B/zh
Publication of CN104892494A publication Critical patent/CN104892494A/zh
Application granted granted Critical
Publication of CN104892494B publication Critical patent/CN104892494B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/22Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing two or more pyridine rings directly linked together, e.g. bipyridyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/127Preparation from compounds containing pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Catalysts (AREA)
  • Pyridine Compounds (AREA)

Abstract

本发明公开了一种4,4'‑二甲基‑2,2'‑联吡啶的制备方法,属于太阳能电池光敏催化剂的合成技术领域。本发明的技术方案要点为:(1)将4‑甲基吡啶置于反应容器中并加入醋酸溶解,分两次加入质量浓度为30%的双氧水,然后于室温下进行氧化反应制得N‑氧化吡啶;(2)加入钯碳催化剂并升温至60‑80℃回流使N‑氧化吡啶发生偶联反应,再加入三氯化磷进行脱氧,然后减压抽滤滤去不溶物,将滤液减压蒸去溶剂后得到白色晶体4,4'‑二甲基‑2,2'‑联吡啶。本发明直接利用吡啶环上N原子被氧化的4‑甲基吡啶氧化物作为中间体,再用钯碳催化偶联,用三氯化磷脱氧,省去了卤代吡啶的合成,节约了生产成本,而且该方法产率较高,适用于工业化生产。

Description

一种4,4'-二甲基-2,2'-联吡啶的制备方法
技术领域
本发明属于太阳能电池光敏催化剂的合成技术领域,具体涉及一种4,4'-二甲基-2,2'-联吡啶的制备方法。
背景技术
当今,缺电子的六元杂环化合物是一类非常重要的有机物,其中含氮杂环化合物,如吡啶以及吡啶衍生物是比较重要的一类。含氮杂环化合物由于其水溶性较大,结构稳定以及其独特的生物活性、低毒性和高内吸性,常被用于医药和农药的结构单元,广泛应用于医药、农药、染料和橡胶制品等工业领域。此外,含氮杂环化合物作为π电子共轭杂环和刚性平面的化合物,具有强烈的荧光效应,能用于染料和太阳能电池。太阳能电池作为一种清洁且环境无污染的新型电池,其研究对于环境保护具有重要的意义。吡啶是最基本、最典型的含氮六元杂环芳香化合物,吡啶以及吡啶衍生物被广泛作为太阳能电池光敏催化剂进行研究。研究结果表明,随着π电子共轭体系的增大,分子的荧光效应也会大大增强,可提高光电转换效率。因此合成吡啶的大共轭体系具有重要的意义。
Hasson等人以卤代吡啶为原料,以钯等过渡金属络合物为催化剂,合成得到了联吡啶。但是若要合成4,4’-二甲基-2,2’-联吡啶,需要首先制得4-甲基-2-氯吡啶,增加了反应步骤和生产成本。吴晓宏等人以4-甲基吡啶为原料、钯碳为催化剂,直接制备了4,4’-二甲基-2,2’-联吡啶,该制备方法虽然反应简单,产品纯度也较高,但是该方法制得的4,4’-二甲基-2,2’-联吡啶的收率为72.7%,收率相对较低,不能直接用于工业生产,因此限制了该方法的现实应用。
4,4’-二甲基-2,2’-联吡啶因具有N和O两种配体,能与多种金属离子形成配合物,在化工合成和太阳能电池光敏催化剂中应用广泛,因此研究该化合物的新型高效的合成方法具有重要的应用价值和现实意义。
发明内容
本发明解决的技术问题是提供了一种操作简单且产率较高的4,4'-二甲基-2,2'-联吡啶的制备方法,该方法原料简单易得,反应步骤较少,产物收率较高,适于大规模工业化生产。
本发明为解决上述技术问题采用如下技术方案,一种4,4'-二甲基-2,2'-联吡啶的制备方法,其特征在于包括以下步骤:(1)将4-甲基吡啶置于反应容器中并加入醋酸溶解,分两次加入质量浓度为30%的双氧水(保持氧化的浓度,防止浓度过高出现危险),然后于室温下进行氧化反应制得N-氧化吡啶;(2)加入钯碳催化剂并升温至60-80℃回流使N-氧化吡啶发生偶联反应,再加入三氯化磷进行脱氧,然后减压抽滤滤去不溶物,将滤液减压蒸去溶剂后得到白色晶体,该白色晶体用乙酸乙酯重结晶和纯化后制得4,4'-二甲基-2,2'-联吡啶。
进一步限定,制备过程中1g 4-甲基吡啶对应质量浓度为30%的双氧水16-32mL。
进一步限定,制备过程中4-甲基吡啶与钯碳催化剂的质量比为1:0.0012-0.025。
进一步限定,制备过程中1g 4-甲基吡啶对应醋酸10-20mL。
进一步限定,制备过程中4-甲基吡啶与三氯化磷的摩尔比为1:1-1.2。
本发明与现有技术相比具有以下有益效果:(1)反应体系简单,仅使用醋酸和质量浓度为30%的双氧水这些普通试剂,成本相对低廉;(2)操作简单,只需要回流一次和重结晶一次,而且耗时较少,获得产物的效率较高,适于大规模生产。本发明直接利用吡啶环上N原子被氧化的4-甲基吡啶氧化物作为中间体,再用钯碳催化偶联,用三氯化磷脱氧,省去了卤代吡啶的合成,节约了生产成本,而且该方法产率较高,适用于工业化生产。
具体实施方式
以下通过实施例对本发明的上述内容做进一步详细说明,但不应该将此理解为本发明上述主题的范围仅限于以下的实施例,凡基于本发明上述内容实现的技术均属于本发明的范围。
实施例1
称取0.93g分析纯的4-甲基吡啶,加入到反应瓶中,再加入10mL醋酸溶解原料,分两次加入15mL质量浓度为30%的双氧水,于室温下静置,使4-甲基吡啶发生氧化反应。3.5h后,加入0.0012g钯碳催化剂,于65℃油浴下,加热回流反应。大约6h后,停止反应。待反应液冷却至室温后,加入145g三氯化磷进行脱氧,然后使用布氏漏斗对反应瓶内液体进行减压抽滤操作,滤去不溶物质。将滤液减压蒸去溶剂,所得剩余物为白色晶体。将该白色晶体用20mL乙酸乙酯进行重结晶。将所得晶体真空干燥。称重,所得4,4’-二甲基-2,2’-联吡啶0.7720g,收率83.8%。
实施例2
称取0.93g分析纯的4-甲基吡啶,加入到反应瓶中,再加入10mL醋酸溶解原料,分两次加入15mL质量浓度为30%的双氧水,于室温下静置,使4-甲基吡啶发生氧化反应。3.5h后,加入0.0059g钯碳催化剂,于65℃油浴下,加热回流反应。大约6h后,停止反应。待反应液冷却至室温后,加入145g三氯化磷进行脱氧,然后使用布氏漏斗对反应瓶内液体进行减压抽滤操作,滤去不溶物质。将滤液减压蒸去溶剂,所得剩余物为白色晶体。将该白色晶体用20mL乙酸乙酯进行重结晶。将所得晶体真空干燥。称重,所得4,4’-二甲基-2,2’-联吡啶0.7812g,收率84.8%。
实施例3
称取0.93g分析纯的4-甲基吡啶,加入到反应瓶中,再加入10mL醋酸溶解原料,分两次加入15mL质量浓度为30%的双氧水,于室温下静置,使4-甲基吡啶发生氧化反应。3.5h后,加入0.0118g钯碳催化剂,于65℃油浴下,加热回流反应。大约6h后,停止反应。待反应液冷却至室温后,加入137g三氯化磷进行脱氧,然后使用布氏漏斗对反应瓶内液体进行减压抽滤操作,滤去不溶物质。将滤液减压蒸去溶剂,所得剩余物为白色晶体。将该白色晶体用20mL乙酸乙酯进行重结晶。将所得晶体真空干燥。称重,所得4,4’-二甲基-2,2’-联吡啶0.8678g,收率94.2%。
实施例4
称取0.93g分析纯的4-甲基吡啶,加入到反应瓶中,再加入10mL醋酸溶解原料,分两次加入15mL质量浓度为30%的双氧水。于室温下静置,使4-甲基吡啶发生氧化反应。3.5h后,加入0.0237g钯碳催化剂,于65℃油浴下,加热回流反应。大约6h后,停止反应。待反应液冷却至室温后,加入137g三氯化磷进行脱氧,然后使用布氏漏斗对反应瓶内液体进行减压抽滤操作,滤去不溶物质。将滤液减压蒸去溶剂,所得剩余物为白色晶体。将该白色晶体用20mL乙酸乙酯进行重结晶。将所得晶体真空干燥。称重,所得4,4’-二甲基-2,2’-联吡啶0.8614g,收率94.6%。
实施例5
称取0.93g分析纯的4-甲基吡啶,加入到反应瓶中,再加入15mL醋酸溶解原料,分两次加入15mL质量浓度为30%的双氧水。于室温下静置,使4-甲基吡啶发生氧化反应。3.5h后,加入0.0118g钯碳催化剂,于65℃油浴下,加热回流反应。大约6h后,停止反应。待反应液冷却至室温后,加入165g三氯化磷进行脱氧,然后使用布氏漏斗对反应瓶内液体进行减压抽滤操作,滤去不溶物质。将滤液减压蒸去溶剂,所得剩余物为白色晶体。将该白色晶体用20mL乙酸乙酯进行重结晶。将所得晶体真空干燥。称重,所得4,4’-二甲基-2,2’-联吡啶0.8585g,收率93.2%。
实施例6
称取0.93g分析纯的4-甲基吡啶,加入到反应瓶中,再加入20mL醋酸溶解原料,分两次加入15mL质量浓度为30%的双氧水。于室温下静置,使4-甲基吡啶发生氧化反应。3.5h后,加入0.0118g钯碳催化剂,于65℃油浴下,加热回流反应。大约6h后,停止反应。待反应液冷却至室温后,加入165g三氯化磷进行脱氧,然后使用布氏漏斗对反应瓶内液体进行减压抽滤操作,滤去不溶物质。将滤液减压蒸去溶剂,所得剩余物为白色晶体。将该白色晶体用20mL乙酸乙酯进行重结晶。将所得晶体真空干燥。称重,所得4,4’-二甲基-2,2’-联吡啶0.8972g,收率97.4%。
实施例7
称取0.93g分析纯的4-甲基吡啶,加入到反应瓶中,再加入20mL醋酸溶解原料,分两次加入20mL质量浓度为30%的双氧水。于室温下静置,使4-甲基吡啶发生氧化反应。3.5h后,加入0.0118g钯碳催化剂,于65℃油浴下,加热回流反应。大约6h后,停止反应。待反应液冷却至室温后,加入145g三氯化磷进行脱氧,然后使用布氏漏斗对反应瓶内液体进行减压抽滤操作,滤去不溶物质。将滤液减压蒸去溶剂,所得剩余物为白色晶体。将该白色晶体用20mL乙酸乙酯进行重结晶。将所得晶体真空干燥。称重,所得4,4’-二甲基-2,2’-联吡啶0.8935g,收率97.0%。
实施例8
称取0.93g分析纯的4-甲基吡啶,加入到反应瓶中,再加入20mL醋酸溶解原料,分两次加入25mL质量浓度为30%的双氧水。于室温下静置,使4-甲基吡啶发生氧化反应。3.5h后,加入0.0118g钯碳催化剂,于65℃油浴下,加热回流反应。大约6h后,停止反应。待反应液冷却至室温后,加入145g三氯化磷进行脱氧,然后使用布氏漏斗对反应瓶内液体进行减压抽滤操作,滤去不溶物质。将滤液减压蒸去溶剂,所得剩余物为白色晶体。将该白色晶体用20mL乙酸乙酯进行重结晶。将所得晶体真空干燥。称重,所得4,4’-二甲基-2,2’-联吡啶0.8825g,收率95.8%。
实施例9
称取0.93g分析纯的4-甲基吡啶,加入到反应瓶中,再加入20mL醋酸溶解原料,分两次加入30mL质量浓度为30%的双氧水。于室温下静置,使4-甲基吡啶发生氧化反应。3.5h后,加入0.0118g钯碳催化剂,于75℃油浴下,加热回流反应。大约6h后,停止反应。待反应液冷却至室温后,加入145g三氯化磷进行脱氧,然后使用布氏漏斗对反应瓶内液体进行减压抽滤操作,滤去不溶物质。将滤液减压蒸去溶剂,所得剩余物为白色晶体。将该白色晶体用20mL乙酸乙酯进行重结晶。将所得晶体真空干燥。称重,所得4,4’-二甲基-2,2’-联吡啶0.8696g,收率94.4%。
图谱数据
目标产物4,4’-二甲基-2,2’-联吡啶的结构为:
1H-NMR (DMSO, 300 MHz) δ: 2.40 (s, 6H, 2CH3), 7.27 (d, J=4.9 Hz, 2H,H-5, H-5'), 8.22 (s, 2H, H-3, H-3'), 8.54 (d, J=4.9 Hz, 2H, H-6, H-6')。
元素分析
4,4’-二甲基-2,2’-联吡啶(分子式C12H12N2)计算值:C 78.26,H 6.52,N 15.22;分析值:C 78.28,H 6.88,N 14.87。
以上实施例描述了本发明的基本原理、主要特征及优点,本行业的技术人员应该了解,本发明不受上述实施例的限制,上述实施例和说明书中描述的只是说明本发明的原理,在不脱离本发明原理的范围下,本发明还会有各种变化和改进,这些变化和改进均落入本发明保护的范围内。

Claims (1)

1.一种4,4'-二甲基-2,2'-联吡啶的制备方法,其特征在于包括以下步骤:称取0.93g分析纯的4-甲基吡啶加入到反应瓶中,再加入20mL醋酸溶解4-甲基吡啶,分两次加入20mL质量浓度为30%的双氧水,于室温下静置使4-甲基吡啶发生氧化反应,3.5h后加入0.0118g钯碳催化剂,于65℃油浴下加热回流反应,6h后停止反应,待反应液冷却至室温后加入145g三氯化磷进行脱氧,然后使用布氏漏斗对反应瓶内液体进行减压抽滤操作,滤去不溶物质,将滤液减压蒸去溶剂,所得剩余物为白色晶体,将该白色晶体用20mL乙酸乙酯进行重结晶,将所得晶体真空干燥得到目标产物4,4’-二甲基-2,2’-联吡啶。
CN201510291441.6A 2015-06-01 2015-06-01 一种4,4'‑二甲基‑2,2'‑联吡啶的制备方法 Expired - Fee Related CN104892494B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510291441.6A CN104892494B (zh) 2015-06-01 2015-06-01 一种4,4'‑二甲基‑2,2'‑联吡啶的制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510291441.6A CN104892494B (zh) 2015-06-01 2015-06-01 一种4,4'‑二甲基‑2,2'‑联吡啶的制备方法

Publications (2)

Publication Number Publication Date
CN104892494A CN104892494A (zh) 2015-09-09
CN104892494B true CN104892494B (zh) 2017-08-11

Family

ID=54025513

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510291441.6A Expired - Fee Related CN104892494B (zh) 2015-06-01 2015-06-01 一种4,4'‑二甲基‑2,2'‑联吡啶的制备方法

Country Status (1)

Country Link
CN (1) CN104892494B (zh)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102199120A (zh) * 2011-04-01 2011-09-28 聊城大学 一种2,2'-联吡啶-4,4'-二甲酸的合成方法
CN102731487A (zh) * 2011-04-01 2012-10-17 季昀 衍生自4,4’-二酸-2,2’-双吡啶的三牙配位子、金属错合物及其应用
WO2012153253A2 (en) * 2011-05-06 2012-11-15 Jan Gysbert Hermanus Du Preez Aromatic compounds and metal complexes thereof
WO2013076197A1 (en) * 2011-11-22 2013-05-30 Solvay Sa Dye compounds, method of making the same, and their use in dye-sensitized solar cells

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102199120A (zh) * 2011-04-01 2011-09-28 聊城大学 一种2,2'-联吡啶-4,4'-二甲酸的合成方法
CN102731487A (zh) * 2011-04-01 2012-10-17 季昀 衍生自4,4’-二酸-2,2’-双吡啶的三牙配位子、金属错合物及其应用
WO2012153253A2 (en) * 2011-05-06 2012-11-15 Jan Gysbert Hermanus Du Preez Aromatic compounds and metal complexes thereof
WO2013076197A1 (en) * 2011-11-22 2013-05-30 Solvay Sa Dye compounds, method of making the same, and their use in dye-sensitized solar cells

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
119. New 2,2"-Bipyridine Derivatives and Their Luminescence Properties with Europiurn(III) and Terbiurn(III) Ions);Veli-Matti Mukkala,等;《HELVETICA CHIMICA ACTA》;19921231;第75卷;第1578-1592页 *
4,4’-Bis(trifluoromethyl)-2,2’-bipyridine –a multipurpose ligand scaffold for lanthanoidbased luminescence/19F NMR probes;Tuba Güden-Silber,等;《Dalton Trans.》;20130807;第42卷;13882–13888 *
Pd-Catalyzed Oxidative CH/CH Direct Coupling of Heterocyclic N‑Oxides;Wei Liu,等;《ORGANIC LETTERS》;20130910;第15卷(第18期);4682-4685 *
Preparation and Luminescence Properties of Tris( Bipyridine) Ruthenium (II)-Containing Vinyl Polymers: Ru(bpy)2 (Po1y-6-Vinyl-2,2‘-Bipyridine)Cl2 and Ru(bpy)2(Poly-4-Methy1-4’-Vinyl- 2,2’- Bipyridine)Cl2;KATSUHIRO SUMI,等;《Journal of Polymer Science: Polymer Chemistry Edition》;19841231;第22卷(第12期);第3779-3788页 *
Reactions concerned in tertiary amine N-oxides. XII.The synthesis of asymmetric compounds containing the ferroin or cuproin group;Haginiwa, Joju,等;《Yakugaku Zasshi》;19791231;第99卷(第12期);1176-1180 *
Reactions concerning tertiary amine N-oxides. II. Reactions of pyridine and quinoline series with their N-oxides;Haginiwa, Joju,等;《Yakugaku Zasshi》;19731231;第93卷(第2期);第144-148页 *
Reactions of tertiary amine N-oxides. V. Preparation of asymmetric 2,2"-dipyridyl, 2,2"pyridylquinoline, and pyridylphenanthroline derivatives;Haginiwa, Joju,等;《Yakugaku Zasshi》;19751231;第95卷(第2期);204-210 *
Substituted 2,2"-Bipyridines by Nickel Catalysis: 4,4′-Di-tert-butyl-2,2′-bipyridine;Joseph A.Buonomo,等;《Synthesis》;20131231;第45卷;3099-3102 *
Synthesis and Evaluation of Lipophilic BTBP Ligands for An/Ln Separation in Nuclear Waste Treatment: The Effect of Alkyl Substitution on Extraction Properties and Implications for Ligand Design;Frank W. Lewis,等;《Eur. J. Org. Chem.》;20120112;1509–1519 *
Synthesis of Unsymmetrically Substituted Bipyridines by Palladium-Catalyzed Direct C-H Arylation of Pyridine N-Oxides;Sasa Duric,等;《ORGANIC letters》;20110401;第13卷(第9期);2310-2313 *

Also Published As

Publication number Publication date
CN104892494A (zh) 2015-09-09

Similar Documents

Publication Publication Date Title
CN103058942B (zh) 一种1,2,3-三氮唑化合物的一锅法合成方法
CN110183378B (zh) 一种烟酰胺的衍生物及其催化合成方法
CN102030770A (zh) 一种芳香硼酸酯化合物的制备方法
CN106117216B (zh) 一种常压合成6H-异吲哚[2,1-a]吲哚-6-酮类化合物的方法
CN106146560B (zh) 一种高纯度磷酸特地唑胺的精制方法
EP2840088B1 (en) Method for preparing 5,6,4'-trihydroxyflavone-7-0-d-glucuronic acid
CN112358443B (zh) 一种吡啶化合物及其制备方法
CN104098607A (zh) 含三环己基膦的单膦单氮杂环卡宾镍(ii)配合物及其应用
CN113307804B (zh) 含氟吲哚喹啉类化合物的合成方法及其应用
CN104892494B (zh) 一种4,4'‑二甲基‑2,2'‑联吡啶的制备方法
CN111662264A (zh) 一种香豆素类衍生物的合成方法
CN104628630A (zh) 一种茚衍生物1-吡啶基-2-溴茚及其合成方法
CN113754606B (zh) 吩噁嗪二胺衍生物和/或吩噻嗪二胺衍生物及其制备方法
CN105198791B (zh) 一种药物中间体氮杂螺环化合物的合成方法
CN107043353A (zh) 一种咪唑苯甲醛缩对苯二胺双席夫碱及其制备方法
CN110294725B (zh) 一种海绵呋喃酮的衍生物及其催化合成方法
CN109232616B (zh) (–)-2-(4′-吡啶基)-4,5-蒎烯-吡啶手性银配合物及其制备方法
CN105566221A (zh) 一种稠环酰胺化合物的合成方法
CN108033919B (zh) 以苯乙烯类化合物为原料合成2-苯基喹唑啉酮类化合物的方法
CN107129464B (zh) 一种2,3,5,6-四取代对称吡啶的制备方法
CN108129402B (zh) 以二苯乙炔类化合物为原料合成2-苯基喹唑啉酮类化合物的方法
CN105061421A (zh) 一种制备2-氯-1, 8-萘啶类衍生物的方法
CN107973755B (zh) 一种3-乙酰氨基喹喔啉酮衍生物的制备方法
CN105399683B (zh) 苯并咪唑衍生物及其制备方法
CN101343263A (zh) 一种合成5-硝基-4,5-二氢呋喃衍生物的方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170811

Termination date: 20200601

CF01 Termination of patent right due to non-payment of annual fee